Current trends in development of HDAC-based chemotherapeutics N Cheshmazar, M Hamzeh-Mivehroud, HN Charoudeh, S Hemmati, ... Life Sciences 308, 120946, 2022 | 27 | 2022 |
Aldehyde oxidase at the crossroad of metabolism and preclinical screening N Cheshmazar, S Dastmalchi, M Terao, E Garattini, ... Drug metabolism reviews 51 (4), 428-452, 2019 | 17 | 2019 |
Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies N Cheshmazar, S Hemmati, M Hamzeh-Mivehroud, B Sokouti, M Zessin, ... Journal of Chemical Information and Modeling 62 (10), 2387-2397, 2022 | 8 | 2022 |
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation N Cheshmazar, M Hamzeh-Mivehroud, S Hemmati, H Abolhasani, ... Future Medicinal Chemistry, 2024 | | 2024 |
Rational design, synthesis, biological evaluation and molecular modeling of histone deacetylase inhibitors as anti-breast cancer stem cell agents N Cheshmazar Tabriz University of Medical Sciences, School of Pharmacy, 2022 | | 2022 |